Antisense Therapeutics Ltd: Change of Company Name
Antisense Therapeutics Ltd: Results of Annual General Meeting
Antisense Therapeutics Ltd: Annual General Meeting Presentation
Antisense Therapeutics Ltd: Notice of Annual General Meeting/Proxy Form
Antisense Therapeutics Ltd: Antisense launches Unmarketable Parcels facility
Antisense Therapeutics Ltd: Antisense Therapeutics Corporate Presentation
Antisense Therapeutics Ltd: Share Purchase Plan (SPP) Offer Booklet
Antisense Therapeutics Ltd: Shareholder Newsletter
Antisense Therapeutics Ltd: Chief Executive Officer and Managing Director Appointment
Antisense Therapeutics Ltd: Results of Annual General Meeting
Antisense Therapeutics Ltd: AGM Presentation
Antisense Therapeutics Ltd: Antisense Therapeutics CEO announces retirement
Antisense Therapeutics Ltd: Notice of Annual General Meeting
Antisense Therapeutics Ltd: Non-Executive Director Retirement
Antisense Therapeutics Ltd: ATL1102 Revised Clinical Development Plans Presentation
Antisense Therapeutics Ltd: Long Covid-19 Collaboration Outcomes Presentation
Antisense Therapeutics Ltd: Investor Presentation
Antisense Therapeutics Ltd: Investor Presentation
Antisense Therapeutics Ltd: Bonus Options Issue - Letter to Shareholders
Antisense Therapeutics Ltd: Results of Annual General Meeting
No Data